Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (361-370 of 409) with videos related to

Pageof 41
Sort By:
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
The Journal of Clinical Investigation|April 14, 2009
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancerSimona Nanni, Valentina Benvenuti, Annalisa Grasselli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
The Prostate|January 27, 2022
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samplesElizabeth H Stover, Coyin Oh, Paula Keskula, et al.
Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2012
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysisAndreas Pettersson, Rebecca E Graff, Scott R Bauer, et al.
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.
Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.
Pageof 41

Showing results (361-370 of 409) with videos related to

Sort By:
Pageof 41
Biorxiv : the Preprint Server for Biology|April 10, 2023
Distinct mesenchymal cell states mediate prostate cancer progressionHubert Pakula, Mohamed Omar, Ryan Carelli, et al.
The Journal of Clinical Investigation|April 14, 2009
Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancerSimona Nanni, Valentina Benvenuti, Annalisa Grasselli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2012
Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesisChiara Grisanzio, Lillian Werner, David Takeda, et al.
The Prostate|January 27, 2022
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samplesElizabeth H Stover, Coyin Oh, Paula Keskula, et al.
Nature Genetics|July 21, 2015
Paired exome analysis of Barrett's esophagus and adenocarcinomaMatthew D Stachler, Amaro Taylor-Weiner, Shouyong Peng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 28, 2012
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysisAndreas Pettersson, Rebecca E Graff, Scott R Bauer, et al.
Cancer Discovery|March 15, 2014
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanibNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
Cancer Research|May 18, 2022
Pyruvate Kinase M1 Suppresses Development and Progression of Prostate AdenocarcinomaShawn M Davidson, Daniel R Schmidt, Julia E Heyman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
mRNA expression signature of Gleason grade predicts lethal prostate cancerKathryn L Penney, Jennifer A Sinnott, Katja Fall, et al.
Cell|July 28, 2009
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancerQianben Wang, Wei Li, Yong Zhang, et al.
Pageof 41